SEC 13F Intelligence

Altium Capital Management LLC / ASND

Altium Capital Management LLC’s Ascendis Pharma A/S Position

Does Altium Capital Management LLC own Ascendis Pharma A/S (ASND)? Not currently — the last reported position was 50.0K shares worth $7M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$7M
Q2 2024
Shares
50.0K
% of Portfolio
+2.78%
Quarters Held
3
position exited

Position History ASND

Reported value by quarter
Q4 ’23: $3MQ4 ’23Q1 ’24: $4MQ1 ’24Q2 ’24: $7MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202450.0K$7M+2.78%
Q1 202425.0K$4M+1.50%
Q4 202325.0K$3M+2.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of ASND.